TICKERNOMICS Sign up
Last Update: 2024-12-27 15:27:16
Biomea Fusion Inc. ( BMEA ) https://biomeafusion.com
4.08USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-73.66%
BMEA
SPY
32.66%
-47.15%
BMEA
SPY
108.59%
BMEA
0.00%
SPY
302.52%
BMEA
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
145.25
66.86
0.59
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.01
0.13
1.91
-39.19
0.00
-0.46
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-668.50
-6.84
-595.57
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-100.33
-103.06
0.00
Other Earnings and Cash Flow Stats:
Biomea Fusion Inc. ( BMEA ) Net Income TTM ($MM) is -144.01
Biomea Fusion Inc. ( BMEA ) Operating Income TTM ($MM) is -151.32
Biomea Fusion Inc. ( BMEA ) Owners' Earnings Annual ($MM) is 0.00
Biomea Fusion Inc. ( BMEA ) Current Price to Owners' Earnings ratio is 0.00
Biomea Fusion Inc. ( BMEA ) EBITDA TTM ($MM) is -149.62
Biomea Fusion Inc. ( BMEA ) EBITDA Margin is -595.57%
Capital Allocation:
Biomea Fusion Inc. ( BMEA ) has paid 0.00 dividends per share and bought back -0.566748 million shares in the past 12 months
Biomea Fusion Inc. ( BMEA ) has reduced its debt by 2.523 million USD in the last 12 months
Capital Structure:
Biomea Fusion Inc. ( BMEA ) Interest-bearing Debt ($MM) as of last quarter is 9
Biomea Fusion Inc. ( BMEA ) Annual Working Capital Investments ($MM) are -3
Biomea Fusion Inc. ( BMEA ) Book Value ($MM) as of last quarter is 75
Biomea Fusion Inc. ( BMEA ) Debt/Capital as of last quarter is 12%
Other Balance Sheet Stats:
Biomea Fusion Inc. ( BMEA ) has 87 million in cash on hand as of last quarter
Biomea Fusion Inc. ( BMEA ) has 27 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Biomea Fusion Inc. ( BMEA ) has 36 common shares outstanding as of last quarter
Biomea Fusion Inc. ( BMEA ) has 0 million USD of preferred stock value
Academic Scores:
Biomea Fusion Inc. ( BMEA ) Altman Z-Score is -5.49 as of last quarter
Biomea Fusion Inc. ( BMEA ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Biomea Fusion Inc. ( BMEA ) largest shareholder is Rafferty Asset Management, LLC owning 233848 shares at 0.95 ($MM) value
Hitchcock Michael J.M.(an insider) Bought 10000 shares of Biomea Fusion Inc. ( BMEA ) for the amount of $100600.00 on 2024-09-30
25.02% of Biomea Fusion Inc. ( BMEA ) is held by insiders, and 64.56% is held by institutions
Biomea Fusion Inc. ( BMEA ) went public on 2021-04-16
Other Biomea Fusion Inc. ( BMEA ) financial metrics:
FCF:-113.01
Unlevered Free Cash Flow:0.00
EPS:-3.62
Operating Margin:-668.50
Gross Profit Margin:-6.84
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-172.63
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Biomea Fusion Inc. ( BMEA ) :
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.